| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T52 |
0-219 |
Sentence |
denotes |
In a different neuroinflammatory disease antibodies to cryptic mannose containing glycans were observed in the cerebrospinal fluid of individuals with multiple sclerosis, and in its animal model EAE (Wang et al., 2014). |
| T53 |
220-310 |
Sentence |
denotes |
There again is some precedent for an antigen‐specific therapy for an inflammatory disease. |
| T54 |
311-462 |
Sentence |
denotes |
Injection of these oligomannose glycans coupled to a protein carrier reduced the clinical severity of paralysis in this animal model (Wang, Bhat et al. |
| T55 |
463-469 |
Sentence |
denotes |
2014). |
| T56 |
470-604 |
Sentence |
denotes |
The success in parlaying the oligomannose glycans in MS and in its EAE model, could be emulated in strategies for therapy of COVID‐19. |
